The pursuit of novel therapeutics often hinges on the availability of specialized chemical intermediates that serve as the foundation for drug discovery. 5-Bromoindole (CAS 10075-50-0) has emerged as a compound of significant interest, particularly for its role as a potential inhibitor of Glycogen Synthase Kinase 3 (GSK-3). As a leading manufacturer and supplier of this critical chemical, we understand its importance in advancing research in areas such as Alzheimer's disease, diabetes, and other GSK-3 related conditions.

Our 5-Bromoindole is synthesized to meet the rigorous standards required for pharmaceutical research. Characterized by its off-white to white powder appearance and excellent solubility in methanol, this compound offers a high purity level, typically above 99.0%, ensuring its efficacy and reliability in complex synthetic schemes. The unique structural features of 5-Bromoindole make it an ideal starting material for creating more complex molecules that can modulate GSK-3 activity. Therefore, researchers focusing on GSK-3 inhibitor development will find our product to be a valuable asset.

We are committed to supporting the scientific community by providing accessible and high-quality 5-Bromoindole. As a prominent supplier, we ensure that our manufacturing processes are optimized for consistency and scale. This allows us to offer competitive pricing for 5-Bromoindole, making it an attractive option for both academic institutions and commercial research organizations. Whether you are in the early stages of identifying lead compounds or scaling up for preclinical trials, our reliable supply chain is designed to meet your needs.

To purchase 5-Bromoindole and to obtain detailed specifications, certificates of analysis, or a formal quote, we encourage you to contact us directly. We are eager to serve as your trusted partner for this essential pharmaceutical intermediate. By choosing our 5-Bromoindole, you are securing a high-purity compound from a dedicated manufacturer, facilitating your groundbreaking research into GSK-3 inhibition and beyond.